Study S003218

A Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based Pharmacotherapy for Weight Management Across the Binge Eating Spectrum

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol (PDF)

Registration

Registration: NCT07870538
Acronym: SEM-BEAT
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 96
Start: 2026-08-26
Primary completion: 2028-12
Lead sponsor: Universitaire Ziekenhuizen KU Leuven
Conditions: Obesity & Overweight
Interventions: DRUG:Semaglutide 3,2 mg/ml
Results posted: FALSE
Secondary identifiers: EUDRACT_NUMBER:2026-526016-36

Registered primary outcomes

Change in Body Mass Index (BMI) after semaglutide treatment [From enrollment to the end of treatment at 6 months]
Change in Binge Eating Scale (BES) score after semaglutide treatment [From enrollment to the end of treatment at 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.